Symbol | Exchange | Currency |
|---|
April 29 (Reuters) - BARD1 Life Sciences Ltd BD1.AX :* ANNOUNCES POSITIVE RESULTS FROM INDEPENDENT STUDY TO EVALUATE BARD1 AUTOANTIBODY ASSAY FOR DETECTION OF OVARIAN CANCER
April 13 (Reuters) - BARD1 Life Sciences Ltd BD1.AX :* EXECUTED EXCLUSIVE 2-YEAR OPTION AGREEMENT WITH UNIVERSITY OF LIVERPOOL TO LICENSE 2 NOVEL PROTEIN MARKERS* AGREEMENT TO...
Feb 24 (Reuters) - BARD1 Life Sciences Ltd BD1.AX :* BARD1 LIFE SCIENCES LTD - COMMENCEMENT OF LEGAL PROCEEDINGS AGAINST BARD1* BARD1 LIFE SCIENCES-2 INDIVIDUALS COMMENCED LEGAL...
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. INOVIQ Ltd has a collaboration with The University of Queensland to develop a exosome-based ovarian cancer screening test. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.375 | 1.43 | 1.365 | -0.010 | -0.72% | 342.49K | Sydney | |||
| 4.96 | 5.00 | 4.94 | +0.04 | +0.81% | 1.45M | Sydney | |||
| 21.68 | 22.45 | 21.66 | -0.37 | -1.68% | 326.61K | Sydney | |||
| 0.071 | 0.071 | 0.069 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 33.68 | 34.20 | 33.53 | -0.24 | -0.71% | 362.45K | Sydney | |||
| 3.29 | 3.36 | 3.28 | +0.010 | +0.30% | 1.21M | Sydney | |||
| 2.22 | 2.24 | 2.20 | +0.01 | +0.45% | 10.32M | Sydney | |||
| 0.07 | 0.08 | 0.07 | -0.01 | -13.33% | 132.00K | Sydney | |||
| 48.14 | 49.06 | 48.03 | -0.39 | -0.80% | 319.19K | Sydney | |||
| 0.24 | 0.245 | 0.24 | 0.000 | 0.00% | 45.98K | Sydney | |||
| 31.65 | 32.59 | 31.65 | +0.030 | +0.09% | 1.78M | Sydney | |||
| 1.455 | 1.50 | 1.455 | -0.035 | -2.35% | 84.89K | Sydney | |||
| 0.125 | 0.13 | 0.125 | 0.000 | 0.00% | 884.30K | Sydney | |||
| 2.14 | 2.15 | 2.14 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 1.015 | 1.048 | 0.985 | +0.005 | +0.50% | 774.74K | Sydney |